Waaree Guides FY27 EBITDA INR7,000–7,700 Crore

Waaree Energies Limited — Q4 & FY26 Earnings Call (Quarter & Year ended Mar 31, 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly emphasizes “record-breaking performance”, “on track”, “robust” order book, and “very healthy ROCE/ROE”.
• Forward-looking language is confident: “remain upbeat on our growth prospects” and “guiding for operating EBITDA of INR7,000 crores to INR7,700 crores for FY27.”
• Even when addressing margin pressure, they frame it as temporary/normalizing due to logistics and commodity impacts, with H2 improvement.

2. Key Themes from Management Commentary

• Strong FY26 execution and profitability
• Revenue +84% YoY to INR26,537 cr, operating EBITDA +117% to INR5,909 cr, PAT +101% to INR3,884 cr.
• Total EBITDA surpassed guidance (earlier INR5,500–6,000 cr).
• Capacity leadership + demand visibility
• Module manufacturing capacity ~26 GW; cell capacity 5.4 GW (India’s largest).
• Order book ~INR53,000 cr, pipeline 100+ GW.
• Waaree 2.0: full-stack vertical + horizontal integration
• Committed capex ~$3.5B over two years; TAM expansion claim 4x by 2035.
• Backward integration moves: polysilicon stake (Oman), PV glass (2,500 TPD), ingot/wafer (10 GW in Nagpur).
• Strategic adjacency expansion
• Entry into T&D via ~55% stake in Associated Power Structures Ltd.
• Scaling inverters (4 GW), BESS (20 GWh), green hydrogen electrolyzers (1 GW).
• Retail as a key growth engine
• Retail revenue INR5,515 cr (+84% YoY); management highlights B2C traction and “no incremental go-to-market build required.”
• Margin narrative: structural resilience with near-term volatility
• They attribute Q4 margin softness to silver/copper pricing, logistics/freight spikes, and mix shifts—but expect H2 margin uplift as cell ramp-up and in-house supply increase.

3. Q&A Analysis

Theme A: Q4 margin decline—commodities, logistics, and mix

• Core questions
• Why did operating EBITDA margins decline sharply in Q4 vs Q3?
• What are current realizations for DCR vs non-DCR modules?
• Management response
• Margin pressure due to:
  • “impact of silver pricing and copper pricing”
  • freight/logistics cost spike (“freight has gone through the roofs”)
  • overseas export mix down vs prior quarter
• Realization framing:
  • Non-DCR utility: INR15–16/Wp (with higher commodity pass-through)
  • Retail premium: incremental rupees/Wp premium
  • DCR: INR21–22/Wp (Mono PERC/TOPCon)
• Assessment
• Answer is fairly direct and specific on drivers (commodities + freight + mix).
• However, it doesn’t fully quantify the magnitude of each driver—more qualitative than model-based.

Theme B: G12R transition and production ramp

• Core questions
• Is the G12R conversion shutdown fully complete or spilling into Q1?
• How does transition affect CUF and realizations?
• Management response
• 3 lines converted to G12R; 11 lines working total; 5 lines remain M10R TOPCon.
• Expect CUF recovery: target 330 MW monthly in next 2 months.
• Transition expected to yield “higher number by 10% to 12%” in megawatts and realizations.
• Assessment
• Clear operational status; still uses “phase manner/one quarter” language (some inherent uncertainty).

Theme C: Export mix weakness and order book composition

• Core questions
• Why was export mix lower in Q4?
• What portion of order book is overseas and how much is export vs US-local?
• Management response
• Export constrained by Middle East logistics delays:
  • ships delayed; congestion reduced loading capacity
  • inventory increased due to lots not shipped
• Order book detail:
  • ~65%–70% overseas long-range delivery over 3–4 years
  • Retail ~20% of revenue not included in INR53,000 cr order book
  • US capacity 1.6 GW now → 4.2 GW in 6 months
• Assessment
• Strong explanation for quarter-specific export softness.
• “Overseas revenue vs export-export” terminology is a bit confusing but they clarify US-local manufacturing.

Theme D: US anti-dumping duties / FEOC and supply-chain insulation

• Core questions
• Any “panic negotiation” or pricing/delivery changes due to duties?
• For US LPA/FEOC: do components besides cells (glass, junction box, wafer, etc.) need non-China sourcing?
• Management response
• US insulation:
  • US local capacity ~4.2 GW within 6 months
  • supply chain diversified; alternate markets (Africa/Europe) for cells
• FEOC/LPA:
  • “Except cells, no need.” (for non-FEOC sourcing requirement)
  • But for US manufacturing, components must be non-FEOC starting April ’26 (they later clarify “cell already restricted” and glass becomes a key non-FEOC compliant component)
• Assessment
• Some internal complexity/possible confusion in how they describe FEOC scope (“except cells” vs later “everything and anything” for US manufacturing). This is a credibility risk unless clarified in filings.

Theme E: FY27 EBITDA guidance—how to bridge from Q4 softness

• Core questions
• How does FY27 EBITDA guidance (INR7,000–7,700 cr) reconcile with margin/mix headwinds?
• What role do G12R transition and cell ramp play?
• Management response
• Guidance growth framed as:
  • cell production normalization with 10%–15% upside
  • H2 cell capacity: existing 5.4 GW ramps to 15.5 GW (own module cell supply)
  • guidance includes pre-startup costs of projects going live in FY27
• They also state Waaree 2.0 benefits start in H2 FY27, more in FY28/FY29.
• Assessment
• Reasoning is coherent, but still relies on ramp assumptions and “pre-startup cost” inclusion—analysts may want more bridge detail.

Theme F: Fundraise purpose and capital allocation

• Core questions
• Purpose/timing of fundraise; what it funds in Waaree 2.0?
• Management response
• Enabling resolution to raise up to ~INR10,000 cr.
• Fundraise to deepen Waaree 2.0 platform:
  • de-risk supply chain, localize BOM/materials
  • protect margins/ROC longer
  • backward integration (glass, materials, etc.)
• Assessment
• Clear strategic rationale; quantitative use-of-proceeds not fully disclosed in call.

Theme G: Working capital / cash conversion deterioration

• Core questions
• Why did cash from operations % drop sharply vs EBITDA?
• Is it structural (industry overcapacity) or phasing?
• Management response
• Noted inventory build due to logistics disruption (export lots on shores not shipped).
• If inventory normalized, cash conversion returns to 70%–100%.
• Working capital days increased due to inventory and production run-rate doubling while advances stayed similar.
• Assessment
• Management attributes to phasing, not demand collapse—plausible given export logistics explanation.

4. Guidance / Outlook

Explicit guidance (quantitative)

• FY27 operating EBITDA: INR7,000 crores to INR7,700 crores
• Implied margin stability narrative:
• They reiterate long-range EBITDA margin expectation around ~19%–20% (qualitative but tied to margin level).

Implicit signals (qualitative)

• H2 FY27 margin improvement expected as:
• cell ramp-up completes (10-gigawatt cell “going live” in H2)
• more in-house cell supply reduces mix dilution
• Waaree 2.0 financial benefits:
• “core solar module stack capex completed in FY27”
• ingot/wafer and part of battery in FY28
• “’29 you will actually see the entire Waaree 2.0 benefits”
• ALMM II clarity:
• they expect government clarity “within a week” (but they also say timelines are “almost formalization” / June 1 effective).

5. Standout Statements (direct / high-signal)

• Performance & execution
• “delivered yet another year of record-breaking performance”
• “reported total EBITDA… surpassed our guidance range”
• Capacity & demand
• “Our total module manufacturing capacity now stands at approximately 26 gigawatts”
• “order book… approximately INR53,000 crores”
• “record pipeline remains robust at 100 plus gigawatts”
• Margin drivers
• Margin decline attributed to: “impact of silver pricing and copper pricing” and “freight has gone through the roofs”
• US duty insulation
• “local 4.2-gigawatt capacity within the next six months”
• Guidance
• “guiding for operating EBITDA of INR7,000 crores to INR7,700 crores for financial year 27”
• Waaree 2.0 timeline
• “Waaree 2.0 results from H2 this year and going to a different level in FY28”
• “’29 you will actually see the entire Waaree 2.0 benefits”
• Fundraise
• “enabling resolution to raise up to INR10,000 odd crores”

6. Red Flags / Positive Signals

Red flags
– FEOC/LPA sourcing scope ambiguity: they say “Except cells, no need” but later imply broader non-FEOC sourcing for US manufacturing components (“everything and anything… has to come from a non-FEOC source”). This could confuse investors and may require clarification in written disclosures.
– Margin explanation remains partly qualitative: commodity + freight + mix are cited, but not fully decomposed into quantified basis points.
– Working capital/cash conversion: they attribute to logistics phasing; investors will watch whether normalization truly occurs next quarter.

Positive signals
– Clear operational ramp narrative (G12R conversion status, CUF targets, cell ramp assumptions).
– Order book strength + long-range overseas share (65%–70% over 3–4 years).
– Consistent “H2 improvement” linkage to cell ramp and in-house supply—internally coherent with guidance.

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current call (Apr 30, 2026): Optimistic
• Prior calls (Jul 30, 2025; Oct 17, 2025; Jan 22, 2026): also Optimistic
• Shift: still upbeat, but more emphasis on execution under macro shocks (Middle East logistics + commodity spikes) and more detailed operational explanations (G12R lines, CUF targets).
• Guidance behavior: they provide FY27 EBITDA range now (they previously guided FY26 EBITDA range and were more cautious about medium-term in earlier periods).

b. Tracking Past Commitments vs Outcomes

1) FY26 EBITDA guidance overachieved
– Past statement (Jan 22, 2026 call): “surpassing our guidance range… INR5,500 to INR6,000 crores” (they were already saying they expected to surpass).
– What happened by current call: “reported total EBITDA… surpassed our guidance range” and FY26 operating EBITDA INR5,909 cr.
– Flag: ✅ Delivered (at least on EBITDA; they explicitly confirm surpassing guidance).

2) US capacity ramp / insulation
– Past (Oct 17, 2025): US manufacturing ramp and FEOC compliance emphasized; local capacity expansion planned.
– Current: US local capacity 1.6 GW → 4.2 GW in 6 months.
– Flag: ✅/⏳ Mostly delivered on narrative; exact ramp milestones are claimed rather than audited in call.

3) Cell ramp to improve utilization
– Past (Jan 22, 2026): expectation of utilization improvement with G12R upgrades; “north of 85% or 90%” trajectory.
– Current: they acknowledge transition drag in Q4 and expect CUF recovery and 10%–12% upside.
– Flag: ⏳ Delayed/volatile (Q4 margin softness and transition imply ramp wasn’t perfectly smooth).

c. Narrative Shifts

• Retail becomes more central:
• Earlier calls: retail mentioned as growing/diversifying.
• Current call: retail is explicitly a major growth lever with 20% revenue contribution and “excited going forward.”
• Margin story evolves:
• Earlier: “structural stability” and gross margin management.
• Current: more explicit acknowledgement of commodity + logistics shocks impacting quarterly margins, though still framed as temporary.
• FEOC/US compliance becomes more operationally detailed:
• Current call includes component sourcing nuance and non-FEOC claims.

d. Consistency & Credibility Signals

• Medium credibility (not high) due to:
• FEOC sourcing scope inconsistency in Q&A
• reliance on ramp assumptions (H2/FY28/FY29 benefit timing) without hard checkpoints
• Strength: operational details (line conversions, CUF targets, capacity additions) are more concrete than earlier purely strategic narratives.

e. Evolution of Key Themes

• Demand: consistently bullish; now supported by more quantified order book/pipeline and policy references.
• Margins: from “stable/structural” → “quarterly volatility due to commodities/logistics” → “H2 normalization via in-house cell supply.”
• Integration: continues to expand; glass + T&D + polysilicon stake are new/expanded emphasis in FY26.
• Regulatory: ALMM/FEOC increasingly treated as a competitive moat rather than just compliance.

f. Additional Insights (cross-period intelligence)

• The cash conversion deterioration in FY26 Q4 appears linked to export logistics disruption—a theme that also explains export mix weakness. This suggests that operational disruptions can temporarily mask underlying demand strength, and investors should separate order book strength from shipment timing.
• Management’s repeated “H2 improvement” suggests they expect the ramp/mix to correct, but the history of transition-related volatility (G12R) implies investors should monitor whether each “next quarter” normalization actually materializes.